companiesandmarkets.com

Return to Report | Print

ADVENTRX Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis

http://www.companiesandmarkets.com/Summary-Company-Profile/adventrx-pharmaceuticals-inc-corporate-and-strategic-assessment-report-company-strategy,-swot-analysis-46028.asp

Report Summary

Introduction

ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on anticancer and antiviral treatments that improve the performance and safety of existing drugs by addressing significant problems such as drug metabolism, toxicity, bioavailability or resistance. It has developed a strong proprietary pipeline as a result of its acquisition of SD Pharmaceuticals in April 2006

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    In November 2007, ADVENTRX decided to discontinue its Phase III clinical trial of CoFactor, its lead candidate, for the first-line treatment of metastatic colorectal cancer following advice received from the Data Safety Monitoring Board (DSMB).

    Being a development stage company, ADVENTRX did not record any revenues over 2002-2006.

    The company's key objective is to advance clinical development of its lead candidate, CoFactor (ANX-510). To achieve this, Dendreon plans to enter into collaborations related to CoFactor.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    Company Financials 10
    Stock Market Performance 10
    P&L 11
    Balance Sheet 13
    Cash Flow 13
    Products & Services 14
    Pipeline Products 14
    Competitors and Strategic Business Relationships 17
    Top Competitors 17
    Key Suppliers 17
    Key Clients 17
    Shareholding Structure 19
    Strategy 20
    Company View 20
    Corporate Strategy 21
    SWOT Analysis 22
    Overview 22
    Strengths 23
    Weaknesses 24
    Opportunities 25
    Threats 27
    Value Chain Analysis 29
    Overview 29
    Product Development 29
    Key Employees 30
    List of Key Employees 30
    Key Employee Biographies 31
    Financial and Operational Overview 37
    Financial and Operational Overview 37
    Appendix 39
    Ask the analyst 39
    Datamonitor consulting 39
    Disclaimer 39


    TABLE OF FIGURES
    Figure 1: ADVENTRX Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12


    TABLE OF TABLES
    Table 1: ADVENTRX Pharmaceuticals - Key Facts 6
    Table 2: ADVENTRX Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($) 10
    Table 3: ADVENTRX Pharmaceuticals - Key Events Impacting Share Price Performance 10
    Table 4: ADVENTRX Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
    Table 5: ADVENTRX Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn) 13
    Table 6: ADVENTRX Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn) 13
    Table 7: ADVENTRX Pharmaceuticals – In-house Pipeline Products 14
    Table 8: ADVENTRX Pharmaceuticals – Collaboration Pipeline Products 16
    Table 9: ADVENTRX Pharmaceuticals – Top Competitors 17
    Table 10: ADVENTRX Pharmaceuticals – Key Suppliers 17
    Table 11: ADVENTRX Pharmaceuticals – Key Clients 18
    Table 12: ADVENTRX Pharmaceuticals - Key Shareholders 19
    Table 13: ADVENTRX Pharmaceuticals - SWOT Analysis Summary 22
    Table 14: ADVENTRX Pharmaceuticals – Value Chain Analysis 29
    Table 15: ADVENTRX Pharmaceuticals - Key Employees 30
    Table 16: ADVENTRX Pharmaceuticals – Financial and Operational Overview 37